Kara Cannon - Feb 21, 2024 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Executive Officer, Director
Signature
/s/ Kara Cannon
Stock symbol
ENZ
Transactions as of
Feb 21, 2024
Transactions value $
$0
Form type
4
Date filed
2/27/2024, 07:22 PM
Previous filing
Sep 5, 2023
Next filing
May 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock Options Exercise $0 +10.6K +3.59% $0.00 307K Feb 21, 2024 Direct F1
transaction ENZ Common Stock Tax liability $0 -5.82K -1.9% $0.00 301K Feb 21, 2024 Direct F2
transaction ENZ Common Stock Award $0 +150K +49.78% $0.00 451K Feb 23, 2024 Direct F3
holding ENZ Common Stock 45.1K Feb 21, 2024 401k
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued, on February 21, 2024, for no consideration pursuant to a Performance Share Award that vested in full on November 3, 2023.
F2 Represents shares withheld by Enzo Biochem, Inc. upon the issuance of the shares described in Footnote 1 above to satisfy tax withholding requirements.
F3 The Reporting Person was granted Restricted Stock Units that will fully vest, subject to the individual's continued employment with Enzo Biochem, Inc, in three equal annual installments over the course of three years, commencing on the first anniversary of the grant date; provided, that, they shall vest in full earlier upon the occurrence of a Change of Control.